Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA5 | P11021 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | PNMT | P11086 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.45 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL49745 | 0.85 | HSPA5 (1.00) | HSPA5ALDH1A1KEAP1IDO1HIF1A | |
| SCHEMBL10470450 | 0.85 | HSPA5 (0.64) | HSPA5ALDH1A1KEAP1IDO1HIF1A | |
| SCHEMBL29519238 | 0.85 | IDO1 (0.62) | IDO1PNMTTSHRCYP2D6TAAR1 | |
| SCHEMBL29357407 | 0.85 | HSPA5 (1.00) | HSPA5ALDH1A1KEAP1IDO1HIF1A | |
| SCHEMBL672407 | 0.85 | IDO1 (0.62) | IDO1PNMTTSHRCYP2D6TAAR1 | |
| SCHEMBL2305654 | 0.84 | HSPA5 (0.61) | HSPA5ALDH1A1KEAP1IDO1PNMT | |
| SCHEMBL16637058 | 0.83 | HSPA5 (0.55) | HSPA5ALDH1A1KEAP1IDO1PNMT | |
| SCHEMBL29839938 | 0.83 | HSPA5 (0.94) | HSPA5ALDH1A1KEAP1IDO1HIF1A | |
| Ammonia Solution, Strong SCHEMBL28323965 | 0.83 | HSPA5 (0.94) | HSPA5ALDH1A1KEAP1IDO1HIF1A | |
| SCHEMBL7809667 | 0.83 | HSPA5 (0.94) | HSPA5ALDH1A1KEAP1IDO1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590963-B2 | Anti-cancer treatment of preselected subjects and screening methods to identify susceptible subjects | TUDAG TU DRESDEN AKTIENGESELLSCHAFT (DE) | 2026-03-31 | — | — | US | disclosed |
| EP-3803402-B1 | ANTI-CANCER TREATMENT OF PRESELECTED SUBJECTS AND SCREENING METHODS TO IDENTIFY SUSCEPTIBLE SUBJECTS | TUDAG TU DRESDEN AG (DE) | 2023-04-26 | — | — | EP | disclosed |
| EP-3578981-B1 | ANTI-CANCER TREATMENT OF PRESELECTED SUBJECTS AND SCREENING METHODS TO IDENTIFY SUSCEPTIBLE SUBJECTS | TUDAG TU DRESDEN AG (DE) | 2021-10-27 | — | — | EP | disclosed |
| US-20210231661-A1 | ANTI-CANCER TREATMENT OF PRESELECTED SUBJECTS AND SCREENING METHODS TO IDENTIFY SUSCEPTIBLE SUBJECTS | TUDAG TU DRESDEN AKTIENGESELLSCHAFT (DE) | 2021-07-29 | — | — | US | disclosed |
| EP-3803402-A1 | ANTI-CANCER TREATMENT OF PRESELECTED SUBJECTS AND SCREENING METHODS TO IDENTIFY SUSCEPTIBLE SUBJECTS | Tudag Tu Dresden Aktiengesellschaft (DE) | 2021-04-14 | — | — | EP | disclosed |
| CN-112534265-A | Screening method for preselecting individual for anti-cancer treatment and identifying individual susceptible to disease | TUDAG德累斯顿工业大学股份公司 | 2021-03-19 | — | — | CN | disclosed |
| WO-2019233779-A1 | ANTI-CANCER TREATMENT OF PRESELECTED SUBJECTS AND SCREENING METHODS TO IDENTIFY SUSCEPTIBLE SUBJECTS | Technische Universität Dresden (DE) | 2019-12-12 | — | — | WO | disclosed |
| US-20030207782-A1 | Aqueous organic dispersions suitable for removing organic films and soils | ECOLAB INC. | 2003-11-06 | — | — | US | disclosed |
| US-6583101-B1 | Synergystic solvent concentrates comprising carbo and acyclic hydroxy ethers, used as antisoilants for substrate surfaces such as floors, photoresists, paints, inks, woven or nonwoven fabrics | ECOLAB INC. | 2003-06-24 | — | — | US | disclosed |
| US-4506103-A | Process for the preparation of o-benzylphenol | BAYER AKTIENGESELLSCHAFT (DE) | 1985-03-19 | — | — | US | disclosed |
| US-4506103-A | Process for the preparation of o-benzylphenol | BAYER AKTIENGESELLSCHAFT (DE) | 1985-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590963-B2 | Anti-cancer treatment of preselected subjects and screening methods to identify susceptible subjects | TPM4, TPM3, TAGLN2 | HSPA5 1582/4885ALDH1A1 2279/4885KEAP1 1845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.